-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Increasingly insensitive to standard drugs: Multi-drug-resistant pathogens are spreading worldwide, and may even threaten the safe treatment of deadly infectious diseases in the near future
"Bacteria resisting some drugs will become a threat.
Rolf Müller is the coordinator of the International Research Alliance for Antibiotic Discovery and Development (IRAADD) and one of about 40 international researchers who hope to jointly avoid the imminent threat of drug resistance (AMR)
AMR: depressing numbers
The numbers say it all
"Although there are currently nearly 4,000 cancer drugs in development, only 30 to 40 new antibacterial drugs
A strategy for discovering and developing new active substances
In its position paper, the League of Nations proposed short- and long-term solutions to solve the resistance problem and fill the pipeline in a sustainable manner
Strong alliance: academic research and industry
Rolf Müller explained: "The recommendations we made in this paper go far beyond the individual measures of the research
DOI 10.
Towards the sustainable discovery and development of new antibiotics